Angiogenesis: A new paradigm for Parkinson disease with practical and pathogenic implications.
From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa, Canada. munozd@smh.ca.
David G
DG
Munoz
From the Neuroscience Research Program (D.G.M.), The Keenan Research Centre of the Li Ka Shing Knowledge Institute and Department of Laboratory Medicine, St. Michael's Hospital; the Department of Laboratory Medicine and Pathobiology (D.G.M.), University of Toronto; the Centre for Cancer Therapeutics (J.M.W.), Ottawa Hospital Research Institute; and the Departments of Pathology and Laboratory Medicine (J.M.W.) and Biochemistry, Microbiology and Immunology (J.M.W.), University of Ottawa, Canada.
John M
JM
Woulfe
D005260:Female; D006801:Humans; D008297:Male; D009389:Neovascularization, Pathologic / Q000134:cerebrospinal fluid* / Q000175:diagnosis*; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis*